Results 91 to 100 of about 518,651 (310)

Comorbidity of infectious diseases and anxiety disorders in adults and its association with quality of life: a community study [PDF]

open access: yes, 2014
Infectious diseases and anxiety disorders are common and both are associated with substantial burden to individual, families, and society. A better understanding of their association may be helpful in explicating possible etiological mechanisms related ...
Meyer, Andrea Hans   +12 more
core   +1 more source

Urinary metabolomics reveals potential biomarkers for monitoring carbon black exposure-related airway injury

open access: yesFrontiers in Public Health
BackgroundCarbon black (CB) exposure is a well-established cause of pulmonary injury, yet sensitive and practical biomarkers for early detection remain lacking. This study aims to address this gap.
Rou Wen   +12 more
doaj   +1 more source

Is gain in health-related quality of life after a total hip arthroplasty depended on the comorbidity burden?

open access: yesActa Orthopaedica, 2018
Background and purpose — Using patient-reported health-related quality of life (HRQoL), approximately 10% of patients report some degree of dissatisfaction after a total hip arthroplasty (THA).
Eva N Glassou   +4 more
doaj   +1 more source

Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis

open access: yesFrontiers in Medicine, 2018
IntroductionComorbidities influence the prognosis, clinical outcomes, disease activity, and treatment response in rheumatoid arthritis (RA). RA patients have a high-comorbidity burden necessitating their study.
Fawad Aslam, Nasim Ahmed Khan
doaj   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges

open access: yes, 2019
Comorbid disorders are highly prevalent in patients with social anxiety disorder, occurring in as many as 90% of patients. The presence of comorbidity may affect the course of the disease in several ways such as comorbidity in patients with social ...
Raşit Tükel   +3 more
core   +1 more source

The association betweeen psychopathology and substance use in young people [PDF]

open access: yes, 2011
Includes abstract.Includes bibliographical references.The co-occurrence of problematic substance use and non-substance use psychopathology is very common in psychiatry, and is generally referred to as comorbidity.
Saban, Amina
core   +1 more source

Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) is the most severe late‐onset condition caused by a premutation in the FMR1 gene, characterized by expanded CGG triplet repeats of 55–200. Clinical presentations of FXTAS, including gait ataxia, kinetic tremor, cognitive decline, and rare Parkinsonism, are linked to ...
Flora Tassone   +8 more
wiley   +1 more source

Comorbidities in psoriasis

open access: yesIndian Journal of Dermatology, Venereology, and Leprology, 2013
Moderate to severe psoriasis is associated with concomitant diseases that may have a significant impact on patients. It is necessary for the treating physician to recognize these concomitant diseases, known as comorbidities, early as they influence the management options.
openaire   +2 more sources

[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy